These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20302562)

  • 1. Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.
    Atik OS; Suluova F; Görmeli G; Yildirim A; Ali AKh
    Eklem Hastalik Cerrahisi; 2010 Apr; 21(1):56-9. PubMed ID: 20302562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of bilateral femoral stress fractures related with long-term alendronate therapy.
    Kanatlı U; Ataoğlu MB; Özer M; Topçu HN; Çetinkaya M
    Eklem Hastalik Cerrahisi; 2017 Apr; 28(1):55-8. PubMed ID: 28291441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.
    Kao CM; Huang PJ; Chen CH; Chen SJ; Cheng YM
    Kaohsiung J Med Sci; 2012 Oct; 28(10):555-8. PubMed ID: 23089322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
    Lee JK
    Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical femoral fracture following zoledronic acid treatment.
    Ataoğlu B; Kaptan AY; Eren TK; Yapar AE; Berkay AF
    Eklem Hastalik Cerrahisi; 2016; 27(1):54-7. PubMed ID: 26874637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
    Ng YH; Gino PD; Lingaraj K; Das De S
    Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause practitioner perspective on the American Society of Bone and Mineral Research Task Force report on atypical femoral fracture.
    Ettinger B; Stuenkel CA; Schnatz PF
    Menopause; 2013 Oct; 20(10):1092-7. PubMed ID: 24048261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporotic fractures and vitamin D deficiency.
    Wong P; Anpalahan M
    Aust Fam Physician; 2006 Jul; 35(7):519-20, 522. PubMed ID: 16820826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
    Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
    Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-energy femoral shaft fractures associated with alendronate use.
    Neviaser AS; Lane JM; Lenart BA; Edobor-Osula F; Lorich DG
    J Orthop Trauma; 2008; 22(5):346-50. PubMed ID: 18448990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case reports: two femoral insufficiency fractures after long-term alendronate therapy.
    Sayed-Noor AS; Sjödén GO
    Clin Orthop Relat Res; 2009 Jul; 467(7):1921-6. PubMed ID: 19198962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
    Angthong C; Angthong W
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S214-20. PubMed ID: 22619933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
    Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
    Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
    [No Abstract]   [Full Text] [Related]  

  • 15. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
    Wang K; Moaveni A; Dowrick A; Liew S
    J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous femoral shaft fracture after long-term alendronate.
    Ali T; Jay RH
    Age Ageing; 2009 Sep; 38(5):625-6. PubMed ID: 19556326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
    Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features.
    Chan SS; Rosenberg ZS; Chan K; Capeci C
    AJR Am J Roentgenol; 2010 Jun; 194(6):1581-6. PubMed ID: 20489100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.
    Lenart BA; Lorich DG; Lane JM
    N Engl J Med; 2008 Mar; 358(12):1304-6. PubMed ID: 18354114
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.